AtriCure Return on Tangible Equity 2010-2025 | ATRC
Current and historical return on tangible equity values for AtriCure (ATRC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| AtriCure Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.04B | $0.17B | -23.15% |
| 2024-12-31 | $-0.05B | $0.17B | -26.95% |
| 2024-09-30 | $-0.04B | $0.17B | -23.46% |
| 2024-06-30 | $-0.04B | $0.17B | -24.43% |
| 2024-03-31 | $-0.04B | $0.16B | -22.84% |
| 2023-12-31 | $-0.03B | $0.17B | -17.91% |
| 2023-09-30 | $-0.02B | $0.16B | -13.99% |
| 2023-06-30 | $-0.03B | $0.16B | -15.45% |
| 2023-03-31 | $-0.04B | $0.18B | -20.56% |
| 2022-12-31 | $-0.05B | $0.18B | -25.38% |
| 2022-09-30 | $-0.06B | $0.18B | -29.95% |
| 2022-06-30 | $0.05B | $0.18B | 27.08% |
| 2022-03-31 | $0.05B | $0.19B | 33.28% |
| 2021-12-31 | $0.05B | $0.21B | 42.74% |
| 2021-09-30 | $0.05B | $0.21B | 57.88% |
| 2021-06-30 | $-0.06B | $0.02B | -147.10% |
| 2021-03-31 | $-0.05B | $0.03B | -105.95% |
| 2020-12-31 | $-0.05B | $0.05B | -1010.53% |
| 2020-09-30 | $-0.05B | $0.05B | 122.45% |
| 2020-06-30 | $-0.05B | $0.05B | 63.43% |
| 2020-03-31 | $-0.05B | $-0.14B | 65.69% |
| 2019-12-31 | $-0.04B | $-0.12B | 269.23% |
| 2019-09-30 | $-0.02B | $-0.11B | -55.00% |
| 2019-06-30 | $-0.02B | $0.09B | -28.88% |
| 2019-03-31 | $-0.02B | $0.09B | -33.16% |
| 2018-12-31 | $-0.02B | $0.10B | -76.19% |
| 2018-09-30 | $-0.02B | $0.01B | -533.33% |
| 2018-06-30 | $-0.02B | $0.00B | -888.89% |
| 2018-03-31 | $-0.03B | $0.00B | -1080.00% |
| 2017-12-31 | $-0.03B | $0.01B | -635.29% |
| 2017-09-30 | $-0.03B | $0.00B | -573.91% |
| 2017-06-30 | $-0.03B | $0.01B | -366.67% |
| 2017-03-31 | $-0.03B | $0.00B | -272.00% |
| 2016-12-31 | $-0.03B | $0.01B | -200.00% |
| 2016-09-30 | $-0.04B | $0.02B | -169.41% |
| 2016-06-30 | $-0.04B | $0.02B | -92.72% |
| 2016-03-31 | $-0.03B | $0.02B | -58.99% |
| 2015-12-31 | $-0.03B | $0.03B | -38.57% |
| 2015-09-30 | $-0.02B | $0.08B | -24.71% |
| 2015-06-30 | $-0.02B | $0.09B | -17.24% |
| 2015-03-31 | $-0.01B | $0.09B | -14.77% |
| 2014-12-31 | $-0.02B | $0.09B | -17.98% |
| 2014-09-30 | $-0.02B | $0.09B | -21.69% |
| 2014-06-30 | $-0.02B | $0.09B | -31.54% |
| 2014-03-31 | $-0.02B | $0.09B | -37.89% |
| 2013-12-31 | $-0.01B | $0.03B | -34.29% |
| 2013-09-30 | $-0.01B | $0.04B | -28.80% |
| 2013-06-30 | $-0.01B | $0.04B | -34.95% |
| 2013-03-31 | $-0.01B | $0.04B | -40.00% |
| 2012-12-31 | $-0.01B | $0.01B | -57.14% |
| 2012-09-30 | $-0.01B | $0.01B | -53.33% |
| 2012-06-30 | $-0.01B | $0.02B | -38.71% |
| 2012-03-31 | $-0.01B | $0.02B | -37.50% |
| 2011-12-31 | $-0.01B | $0.02B | -30.77% |
| 2011-09-30 | $0.00B | $0.02B | -18.18% |
| 2011-06-30 | $0.00B | $0.02B | -18.18% |
| 2011-03-31 | $0.00B | $0.02B | -18.46% |
| 2010-12-31 | $0.00B | $0.02B | -24.62% |
| 2010-09-30 | $-0.01B | $0.02B | -36.92% |
| 2010-06-30 | $-0.01B | $0.02B | -59.70% |
| 2010-03-31 | $-0.01B | $0.02B | -54.79% |
| 2009-12-31 | $-0.02B | $0.02B | -81.01% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.598B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |